Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 18 studies | 46% ± 21% | |
oligodendrocyte | 11 studies | 35% ± 16% | |
GABAergic neuron | 5 studies | 38% ± 22% | |
Mueller cell | 4 studies | 47% ± 18% | |
glutamatergic neuron | 4 studies | 57% ± 13% | |
type II pneumocyte | 4 studies | 27% ± 9% | |
retinal bipolar neuron | 3 studies | 47% ± 21% | |
interneuron | 3 studies | 51% ± 23% | |
neuron | 3 studies | 44% ± 4% | |
ON-bipolar cell | 3 studies | 38% ± 15% | |
rod bipolar cell | 3 studies | 36% ± 15% | |
club cell | 3 studies | 23% ± 6% | |
basal cell | 3 studies | 19% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 99% | 2340.30 | 2605 / 2642 | 93% | 14.99 | 658 / 705 |
thymus | 89% | 761.07 | 578 / 653 | 88% | 25.41 | 531 / 605 |
uterus | 98% | 1237.26 | 167 / 170 | 41% | 6.24 | 186 / 459 |
ovary | 98% | 1364.48 | 176 / 180 | 38% | 3.64 | 165 / 430 |
prostate | 98% | 1298.68 | 240 / 245 | 36% | 2.06 | 179 / 502 |
kidney | 91% | 922.00 | 81 / 89 | 38% | 7.70 | 344 / 901 |
esophagus | 89% | 845.19 | 1283 / 1445 | 40% | 3.42 | 73 / 183 |
breast | 63% | 367.39 | 290 / 459 | 65% | 7.01 | 727 / 1118 |
bladder | 95% | 732.52 | 20 / 21 | 31% | 3.28 | 156 / 504 |
lung | 63% | 471.71 | 363 / 578 | 55% | 8.07 | 637 / 1155 |
intestine | 86% | 800.86 | 829 / 966 | 21% | 1.54 | 112 / 527 |
liver | 68% | 513.88 | 154 / 226 | 29% | 2.76 | 118 / 406 |
skin | 62% | 324.15 | 1122 / 1809 | 33% | 8.39 | 154 / 472 |
eye | 0% | 0 | 0 / 0 | 94% | 15.45 | 75 / 80 |
pancreas | 4% | 15.55 | 14 / 328 | 69% | 6.69 | 122 / 178 |
stomach | 39% | 262.78 | 140 / 359 | 28% | 1.88 | 80 / 286 |
adrenal gland | 40% | 166.12 | 102 / 258 | 19% | 2.74 | 43 / 230 |
adipose | 56% | 340.88 | 669 / 1204 | 0% | 0 | 0 / 0 |
heart | 51% | 217.33 | 442 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 42% | 3.73 | 19 / 45 |
blood vessel | 23% | 104.60 | 305 / 1335 | 0% | 0 | 0 / 0 |
muscle | 13% | 54.80 | 102 / 803 | 0% | 0 | 0 / 0 |
spleen | 7% | 23.06 | 17 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 5% | 24.43 | 46 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.15 | 1 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007218 | Biological process | neuropeptide signaling pathway |
GO_0006886 | Biological process | intracellular protein transport |
GO_0060292 | Biological process | long-term synaptic depression |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0043204 | Cellular component | perikaryon |
GO_0031901 | Cellular component | early endosome membrane |
GO_0098839 | Cellular component | postsynaptic density membrane |
GO_0055038 | Cellular component | recycling endosome membrane |
GO_0005829 | Cellular component | cytosol |
GO_0043197 | Cellular component | dendritic spine |
GO_0016020 | Cellular component | membrane |
GO_0008188 | Molecular function | neuropeptide receptor activity |
Gene name | SORCS2 |
Protein name | Alternative protein SORCS2 Sortilin related VPS10 domain containing receptor 2 VPS10 domain-containing receptor SorCS2 [Cleaved into: SorCS2 122 kDa chain; SorCS2 104 kDa chain; SorCS2 18 kDa chain] |
Synonyms | KIAA1329 |
Description | FUNCTION: The heterodimer formed by NGFR and SORCS2 functions as receptor for the precursor forms of NGF (proNGF) and BDNF (proBDNF) . ProNGF and proBDNF binding both promote axon growth cone collapse (in vitro) . Plays a role in the regulation of dendritic spine density in hippocampus neurons (By similarity). Required for normal neurite branching and extension in response to BDNF . Plays a role in BDNF-dependent hippocampal synaptic plasticity. Together with NGFR and NTRK2, is required both for BDNF-mediated synaptic long-term depression and long-term potentiation . ProNGF binding promotes dissociation of TRIO from the heterodimer, which leads to inactivation of RAC1 and/or RAC2 and subsequent reorganization of the actin cytoskeleton . Together with the retromer complex subunit VPS35, required for normal expression of GRIN2A at synapses and dendritic cell membranes. Required for normal expression of the amino acid transporter SLC1A1 at the cell membrane, and thereby contributes to protect cells against oxidative stress (By similarity). .; FUNCTION: [SorCS2 122 kDa chain]: Does not promote Schwann cell apoptosis in response to proBDNF. .; FUNCTION: SorCS2 104 kDa chain and SorCS2 18 kDa chain together promote Schwann cell apoptosis in response to proBDNF. . |
Accessions | ENST00000505529.1 H0Y9I2 Q96PQ0 B5MED8 ENST00000329016.10 L8ECI9 ENST00000507866.6 |